What's New in CLL?

 

SOHO 2023 Eleventh Annual Meeting
Avatar

SOHO 2023 Next Questions: CLL

By SOHO 2023 Eleventh Annual Meeting FEATURING Nitin Jain
By SOHO 2023 Eleventh Annual Meeting FEATURING Nitin Jain
403 views
October 19, 2023
0 Comments
Login to view comments. Click here to Login
What's New in CLL?
18:50
MyCancerHaven

Experts Discuss the Use of Pirtobrutinib in CLL and MCL

Feat. R. Vij, G. Shouse
20:58
Andrew Lipsky

Recent Updates on the Use of BTK Inhibitors in CLL

44:20
Yale Cancer Center

CLL: Genotype to Phenotype and Beyond

Feat. C. Wu
21:03
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Updates in BTKi-Refractory and BTKi/BCL-2i-Refractory CLL

Feat. S. O'Brien
09:27
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Fixed Duration Treatment in CLL

Feat. J. Kra
08:26
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Pirtobrutinib in Post-cBTKi CLL/SLL - 30 Mo…

Feat. J. Woyach
10:19
Alvaro Alencar

Pirtobrutinib in R/R CLL

05:12
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Fixed-Duration Pirtobrutinib Combined With …

Feat. N. Shah
10:22
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: CLL

Feat. N. Jain
08:45
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of CLL - Highlights & Key Takea…

Feat. V. Yazbeck